Amneal Pharmaceuticals, Class Stock Price on September 30, 2024
| AMRX Stock | USD 8.39 0.07 0.84% |
Below is the normalized historical share price chart for Amneal Pharmaceuticals, Class extending back to January 14, 2009. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Amneal Pharmaceuticals, stands at 8.39, as last reported on the 25th of November, with the highest price reaching 8.43 and the lowest price hitting 8.25 during the day.
If you're considering investing in Amneal Stock, it is important to understand the factors that can impact its price. Amneal Pharmaceuticals, secures Sharpe Ratio (or Efficiency) of -7.0E-4, which signifies that the company had a -7.0E-4% return per unit of risk over the last 3 months. Amneal Pharmaceuticals, Class exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Amneal Pharmaceuticals,'s Mean Deviation of 1.37, risk adjusted performance of 0.0391, and Downside Deviation of 1.84 to double-check the risk estimate we provide.
At this time, Amneal Pharmaceuticals,'s Common Stock is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 3.9 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 151.5 M in 2024. . At this time, Amneal Pharmaceuticals,'s Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.19 in 2024, whereas Price To Sales Ratio is likely to drop 0.42 in 2024. Amneal Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of January 2009 | 200 Day MA 7.1447 | 50 Day MA 8.5696 | Beta 1.175 |
Amneal |
Sharpe Ratio = -7.0E-4
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AMRX |
Estimated Market Risk
| 1.77 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Amneal Pharmaceuticals, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amneal Pharmaceuticals, by adding Amneal Pharmaceuticals, to a well-diversified portfolio.
Price Book 86.1038 | Enterprise Value Ebitda 14.3491 | Price Sales 1.446 | Shares Float 141.5 M | Wall Street Target Price 10.5 |
Related Headline
Bio Path Headline on 30th of September 2024
Acquisition by Sherwood Aline of 2000 shares of Bio Path at ... by Sherwood Aline
Filed transaction by Bio Path Holdings Director. Grant, award or other acquisition pursuant to Rule 16b-3
Amneal Pharmaceuticals, Valuation on September 30, 2024
It is possible to determine the worth of Amneal Pharmaceuticals, on a given historical date. On September 30, 2024 Amneal was worth 8.11 at the beginning of the trading date compared to the closed value of 8.32. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Amneal Pharmaceuticals, stock. Still, in general, we apply an absolute valuation method to find Amneal Pharmaceuticals,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amneal Pharmaceuticals, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Amneal Pharmaceuticals,'s related companies.
| Open | High | Low | Close | Volume | |
| 8.39 | 8.39 | 8.17 | 8.19 | 769,777 | |
09/30/2024 | 8.11 | 8.34 | 8.01 | 8.32 | 1,078,149 |
| 8.38 | 8.94 | 8.38 | 8.70 | 2,557,396 |
| Backtest Amneal Pharmaceuticals, | | | Amneal Pharmaceuticals, History | | | Amneal Pharmaceuticals, Valuation | Previous | Next |
Amneal Pharmaceuticals, Trading Date Momentum on September 30, 2024
| On October 01 2024 Amneal Pharmaceuticals, Class was traded for 8.70 at the closing time. The top price for the day was 8.94 and the lowest listed price was 8.38 . The trading volume for the day was 2.6 M. The trading history from October 1, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 4.57% . The overall trading delta against the current closing price is 3.00% . |
Amneal Pharmaceuticals, Fundamentals Correlations and Trends
By evaluating Amneal Pharmaceuticals,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Amneal Pharmaceuticals,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Amneal financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Amneal Pharmaceuticals, Stock history
Amneal Pharmaceuticals, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Amneal is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Amneal Pharmaceuticals, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Amneal Pharmaceuticals, stock prices may prove useful in developing a viable investing in Amneal Pharmaceuticals,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 176.1 M | 151.5 M | |
| Net Loss | -117 M | -111.1 M |
Amneal Pharmaceuticals, Quarterly Net Working Capital |
|
Amneal Pharmaceuticals, Stock Technical Analysis
Amneal Pharmaceuticals, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Amneal Pharmaceuticals, Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Amneal Pharmaceuticals, Class cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Amneal Pharmaceuticals, November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Amneal Pharmaceuticals, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Amneal Pharmaceuticals, shares will generate the highest return on investment. By undertsting and applying Amneal Pharmaceuticals, stock market strength indicators, traders can identify Amneal Pharmaceuticals, Class entry and exit signals to maximize returns
Amneal Pharmaceuticals, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Amneal Pharmaceuticals,'s price direction in advance. Along with the technical and fundamental analysis of Amneal Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Amneal to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0391 | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.073 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.